PAIRX BIO
PairX Bio is a biotechnology firm that specializes in the development of cancer immunotherapies.
PAIRX BIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.pairxbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Official Site Inspections
http://www.pairxbio.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "PairX Bio"
PairX Bio | Next Generation Cancer Immunotherapies
PairX is pioneering the development of next-generation cancer-selective biologics by identifying novel, highly prevalent, tumor-selective cell surface variants. Founded on IP exclusively licensed from Duke-NUS Medical School, …See details»
PairX Bio - Crunchbase Company Profile & Funding
PairX Bio is a biotechnology firm that specializes in the development of cancer immunotherapies.See details»
PairX Bio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for PairX Bio. Use the PitchBook Platform to explore the full profile.See details»
Duke-NUS spinout PairX Bio launches with strong biotech …
Aug 17, 2020 - Startup to advance innovative biotechnology built on deep expertise in mRNA splicing biology and proprietary immunotherapy platform exclusively licensed from Duke-NUS …See details»
PairX Bio - LinkedIn
PairX Bio | 1,150 followers on LinkedIn. Next Generation Cancer-Selective Biologics | PairX is pioneering the development of next-generation cancer-selective biologics by identifying novel, …See details»
From eureka to an invention that attracts investors - PairX
Investors Esco Ventures X (left) and Avendesora (second right) joined forces with Dr Raymond Lee (second left) and Professor David Epstein (right) to form PairXBioSingapore venture …See details»
Duke-NUS spinout PairX Bio launches with strong biotech …
The company was incubated by Esco Ventures X and spun out from Duke-NUS. The founding investors are Esco Ventures and Avendesora (an investment company represented by Jeffrey …See details»
PairX Bio – Funding, Valuation, Investors, News
Jul 18, 2024 PairX Bio Pte Ltd is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The PairX platform …See details»
PairX Bio - VentureRadar
"PairX Bio Pte Ltd is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The PairX platform is built upon …See details»
PairX Bio Company Profile | Management and Employees List
Find contact information for PairX Bio. Learn about their Business Services market share, competitors, and PairX Bio's email format.See details»
PAIRX BIO PTE. LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PAIRX BIO PTE. LTD. of Singapore. Get the latest business insights from Dun & Bradstreet.See details»
PairX Bio - Company Profile - Tracxn
Mar 7, 2025 PairX Bio - Developer of cancer immunotherapies for the treatment of cancer. Raised funding from 2 investors.See details»
PairX Bio - VentureRadar
PairX Bio Pte Ltd is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The PairX platform is built upon …See details»
Team - PairX
Team - PairX ... TeamSee details»
PairX Bio launches venture capital backing targeting Cancer …
Aug 18, 2020 Singapore based PairX Bio, a next-generation biotechnology startup focusing on cutting-edge cancer immunotherapies, and Duke-NUS Medical School on 17 August 2020 …See details»
PairX Bio Company and Investment Profile | MAGNiTT
PairX Bio Pte Ltd is developing next generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins. The PairX platform is built upon …See details»
PairX Bio | SGInnovate
PairX Bio is a precision oncology company developing next generation therapeutics targeting cancer-associated antigens derived from alternatively spliced proteins. The PairX Bio …See details»
From accidental to essential - Healthcare Asia Magazine
Nov 9, 2021 Founded in September 2020, PairX Bio is a startup that raised several seed financing rounds to help in its mission of developing immunotherapies against cancer.See details»
Duke-NUS spinout PairX Bio launches with strong biotech …
Aug 17, 2020 PairX Bio, a next generation biotechnology startup with exclusive license to Duke-NUS Medical School’s deep expertise and proprietary technology in cancer immunotherapies, …See details»
PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG …
Jul 25, 2024 • The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem, with a doubling …See details»